Standout Papers
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (2010)
- Vemurafenib: the first drug approved for BRAF-mutant cancer (2012)
- Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer (2015)
- Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study (2015)
Immediate Impact
9 by Nobel laureates 24 from Science/Nature 71 standout
Citing Papers
Targeting KRAS in cancer
2024 Standout
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
2023 Standout
Works of K. B. Nolop being referenced
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
2015 Standout
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. B. Nolop | 3543 | 1504 | 3298 | 63 | 7.2k | |
| Ronit Simantov | 5436 | 4224 | 3293 | 87 | 11.0k | |
| Olivier Kocher | 4598 | 2928 | 2828 | 93 | 9.2k | |
| Jeanette M. Wood | 3741 | 803 | 2003 | 104 | 7.5k | |
| Ron Bose | 3491 | 1241 | 3062 | 93 | 6.6k | |
| Violeta Serra | 4096 | 1571 | 2987 | 91 | 7.3k | |
| Gary C. Chamness | 4806 | 1181 | 5649 | 95 | 11.1k | |
| Stephen F. Madden | 4721 | 1002 | 2131 | 160 | 8.0k | |
| Vladimir Lazar | 4011 | 933 | 2103 | 133 | 7.3k | |
| Dilip D. Giri | 2918 | 689 | 2865 | 94 | 6.8k | |
| Wolter J. Mooi | 5695 | 2570 | 4485 | 111 | 11.8k |
All Works
Loading papers...